Trial
NCT03511365
Effects of Probiotic on Inflammation and Microbiota in Patients With NASH
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwell Health
Collaborators
—
Condition
Non-Alcoholic Fatty Liver Disease
Intervention
Probiotic Formulation VSL#3
Why stopped
IRB haulted the study there was no evidence that the probiotic would benefit the patient
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-07